sorry but I don't think so. It is not dead yet. The Company will come out from BK and wait for the right time and money then apply for the FDA approval and some big bio-tech company should buy the stock at $ 10 or $ 20 per share. they have very good product in the pipelines for cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.